Exploring the Mechanism of TACSTD2 Causing Cisplatin Resistance
TACSTD2 has been confirmed to be highly expressed in various cancers, but the mechanism has not been explored in ovarian cancer Overall design: SKOV3 cells were sequenced by knocking out TACSTD2, divided into shNC, sh (sh TACSTD2), shNCDDP (cisplatin), shDDP (shTACSTD2+cisplatin).